Citations

Institution: Mayo Clinic Clear

Showing 10 of 108104 citations.

A community participatory approach to enhancing capacity in patient-centered alcohol research: Bridging translational science and empowering women
Sharma, Pravesh , Kolarik, Hannah , Benny, Christopher Plapparampil, Tranby, Brianna N., Vance, Tessa, Thompson, Tommi, Boehmer, Kasey R. , Patten, Christi A. , Benny, Christopher , Sharma, Pravesh , Patten, Christi , Benny, Christopher , Tranby, Brianna , Vance, Tessa, Thompson, Tommi, Chamberlain, Alanna M.

Journal of Clinical and Translational Science | July 16, 2025 | Volume: 9 | Issue: 1 | Pages: No page available

10.1017/cts.2025.10102 | PMID 40895448 Get It

Abstract Alcohol misuse among women has risen compared to men. Women experience barriers to engaging in patient-centered comparative effectiveness research (CER) that, in turn, limits the evidence base for addressing alcohol misuse in this population. In this manuscript, we describe WomenWise, a community-partnered project and outline how we co-developed community focused CER training curriculum and collaboratively planned future partnered learning sessions (PLSs) with Community Advisory Board (CAB) feedback. Through this approach we aim to empower women to contribute to future patient-centered CER and enhance the stakeholder capacity for future patient-centered research.
An Exploratory Investigation into the Influence of Nasopharyngoscopy Findings on VPI Surgery Selection
Chee-Williams, Jessica L. , Perry, Jamie L. , Bunton, Kate , Sitzman, Thomas J. , Sitzman, Thomas J , Chee-Williams, Jessica L , Perry, Jamie L

The Cleft Palate Craniofacial Journal | July 16, 2025 | Volume: 63 | Issue: 7 | Pages: 1999-2007

10.1177/10556656251359180 | PMID 40665693 Get It

Objective To explore if observations on nasopharyngoscopy influence the surgical procedure selected for the management of velopharyngeal insufficiency (VPI). Design Cross-sectional survey. Participants Seventeen surgeons with experience treating VPI. Interventions Review of twenty-four nasopharyngoscopy videos with a combination of velopharyngeal closure patterns and gap sizes. Main Outcome Measures Surgical procedure was selected after watching a nasopharyngoscopy video. Chi-square tests were used to evaluate if, for each surgeon, procedure selection varied based on closure pattern and gap size combination. Variable importance scores were obtained from a random forest analysis to quantify contribution of nasopharyngoscopy observations on procedure selection. Results Four procedures accounted for 86% of all surgeries selected: Furlow double-opposing Z-Plasty (33%), palatal lengthening using buccal myomucosal flaps (20%), pharyngeal flap (19%), and sphincter pharyngoplasty (14%). Four surgeons (23.5%) significantly varied their surgical selection when different closure pattern and gap size combinations were shown on nasopharyngoscopy. Ten surgeons (58%) selected the same procedure in ≥ 50% of the 24 nasopharyngoscopy videos. Individual surgeon preference was the strongest predictor of surgical selection, accounting for 57.9% of surgical selection variance. Velopharyngeal gap size accounted for 36.5% of the variance in surgical selection, yet the specific surgeries selected based on gap size varied widely across surgeons. Closure pattern was a weak predictor, contributing 5.6% to surgical selection variance. Conclusions Nasopharyngoscopy findings influence VPI surgical procedure selection in a highly individualized, surgeon-specific manner. Among factors observed on nasopharyngoscopy, velopharyngeal gap size has a much larger influence on procedure selection than closure pattern.
Fine‐tuning open‐source large language models to improve their performance on radiation oncology tasks: A feasibility study to investigate their potential clinical applications in radiation oncology
Wang, P. , Liu, Zhengliang , Li, Yiwei , Shu, Peng , Li, Xiang , Laughlin, Brady, Toesca, Diego Santos, Vargas, Carlos , Vora, Sujay A., Patel, Samir H. , Liu, Tianming , Wang, Peilong, Laughlin, Brady S. , Toesca, Diego A.S. , Wang, Peilong, Holmes, Jason , Shu, Peng, Zhang, Lian , Li, Quanzheng , Sio, Terence T. , Liu, Wei , Li, Xiang

Medical Physics | July 16, 2025 | Volume: 52 | Issue: 7 | Pages: No page available

10.1002/mp.17985 | PMID 40665561 Get It

Abstract Background The radiation oncology clinical practice involves many steps relying on the dynamic interplay of abundant text data. Large language models have displayed remarkable capabilities in processing complex text information. But their direct applications in specific fields like radiation oncology remain underexplored. Purpose This study aims to investigate whether fine‐tuning LLMs with domain knowledge can improve the performance on Task (1) treatment regimen generation, Task (2) treatment modality selection (photon, proton, electron, or brachytherapy), and Task (3) ICD‐10 code prediction in radiation oncology. Methods Data for 15 724 patient cases were extracted. Cases where patients had a single diagnostic record, and a clearly identifiable primary treatment plan were selected for preprocessing and manual annotation to have 7903 cases of the patient diagnosis, treatment plan, treatment modality, and ICD‐10 code. Each case was used to construct a pair consisting of patient diagnostics details and an answer (treatment regimen, treatment modality, or ICD‐10 code, respectively) for the supervised fine‐tuning of these three tasks. Open source LLaMA2‐7B and Mistral‐7B models were utilized for the fine‐tuning with the Low‐Rank Approximations method. Accuracy and ROUGE‐1 score were reported for the fine‐tuned models and original models. Clinical evaluation was performed on Task (1) by radiation oncologists, while precision, recall, and F‐1 score were evaluated for Task (2) and (3). One‐sided Wilcoxon signed‐rank tests were used to statistically analyze the results. Results Fine‐tuned LLMs outperformed original LLMs across all tasks with p value ≤ 0.001. Clinical evaluation demonstrated that over 60% of the fine‐tuned LLMs‐generated treatment regimens were clinically acceptable. Precision, recall, and F1‐score showed improved performance of fine‐tuned LLMs. Conclusion Fine‐tuned LLMs demonstrated statistically significant improvements over original LLMs upon three clinically important tasks in radiation oncology. This study explored the feasibility of applying fine‐tuned LLMs in radiation oncology, inspiring further development of utilizing LLMs to assist with radiation oncology tasks.
The role of imaging studies in predicting time to first treatment and overall survival in high‐count monoclonal B‐cell lymphocytosis
Kosydar, Samuel , Archibald, William J. , Hampel, Paul J. , Call, Timothy G. , Achenbach, Sara J., Rabe, Kari G. , Hanson, Curtis A. , Koehler, Amber B. , Muchtar, Eli , Kenderian, Saad S. , Leis, José F., Schwager, Susan M., Wang, Yucai , Hilal, Talal , Parrondo, Ricardo D , Shi, Min , Parikh, Sameer A , Chaffee, Kari G. , Kenderian, Saad Sirop , Muchtar, E , Kosydar, Samuel R , Achenbach, Sara J., Wang, Yucai , Roeker, Lindsey E. , Hilal, Talal , Tsang, Mazie , Braggio, Esteban , Slager, Susan L. , Kay, Neil E. , Parikh, Sameer A.

British Journal of Haematology | July 16, 2025 | Volume: 207 | Issue: 3 | Pages: 860-868

10.1111/bjh.70009 | PMID 40664436 Get It

SummaryIn individuals with high‐count monoclonal B‐cell lymphocytosis (MBL), we investigated if lymphadenopathy or splenomegaly found by imaging was associated with shorter time to first chronic lymphocytic leukaemia (CLL) therapy (TTFT) and overall survival (OS). Individuals with MBL seen at Mayo Clinic (2002–2019) were retrospectively divided into three cohorts based on imaging studies within 1 year of diagnosis: no imaging studies (Cohort A); imaging with no evidence of lymphadenopathy/splenomegaly (Cohort B); imaging with evidence of lymphadenopathy/splenomegaly (Cohort C). We compared baseline characteristics, TTFT and OS across the MBL cohorts to a cohort of individuals with small lymphocytic lymphoma (SLL). A total of 1078 patients were included: 640 with MBL and 438 with SLL. Compared to Cohort B, individuals in Cohort C were more likely to have unmutated immunoglobulin heavy chain variable region (IGHV) (43% vs. 25% p = 0.016), high‐risk fluorescence in situ hybridization (FISH) (del17p and del11q in 15% vs. 4%, p = 0.038) and higher expression of CD38 (31% vs. 16%; p = 0.011). After adjusting for sex and CLL‐International Prognostic Index (IPI), lymphadenopathy/splenomegaly was associated with a shorter TTFT (hazard ratio [HR] = 2.04, 95% confidence interval [CI]: 1.02–4.04, p = 0.042) but not OS (HR = 1.09, 95% CI: 0.62–1.92, p = 0.775). Lymphadenopathy/splenomegaly on imaging in individuals with high‐count MBL is associated with a more unfavourable risk profile and shorter time to first CLL‐directed therapy.
Single pulse electrical stimulation reveals stronger inputs than outputs in dorsal areas
Yanez-Ramos, Maria Guadalupe , Valencia, Gabriela Ojeda , Gregg, Nick, Qadir, Zeeshan , Montoya, Morgan , Miller, Kai J. , Huang, Harvey , Kay, Kendrick , Worrell, Gregory A. , Hermes, Dora

Journal of Vision | July 15, 2025 | Volume: 25 | Issue: 9 | Pages: 2454

10.1167/jov.25.9.2454 Get It

White matter stimulation with single electrical pulses modulates neuronal activity in visual cortex
Valencia, Gabriela Ojeda , Kapeller, Christoph , Shu, Yunhong , Miller, Kai J. , Hermes, Dora, Huang, Harvey , Kay, Kendrick , Gregg, Nicholas M. , Lundstrom, Brian N. , In, Myung‐Ho , Huston, John , Worrell, Gregory A. , Hermes, Dora

Journal of Vision | July 15, 2025 | Volume: 25 | Issue: 9 | Pages: 2264

10.1167/jov.25.9.2264 Get It

Spontaneous Hemo-Mediastinum Following Laparoscopic Appendectomy: A Case Report
Awad, Amir, Theerman, Isaac, McBride, J.F., Awad, Abanoub, McBride, Jeremy F, Beckermann, Jason , Awad, Abanoub A

American Journal of Case Reports | July 15, 2025 | Volume: 26 | Issue: No issue available | Pages: No page available

10.12659/ajcr.949251 | PMID 40717320 Get It

Real-world outcomes of patients with aggressive B-cell lymphoma treated with epcoritamab or glofitamab
Brooks, Taylor , Zabor, Emily C. , Bedelu, Yohanna B., Yang, Xi , Karimi, Yasmin , Nedved, Adrienne, Wang, Yucai , Dave, Nikita, Baron, Margaret Kelsey , Trotier, Daniel, Miller, Jordan A. , Reinert, Catherine, Schwarz, Tenley, Salafian, Kiarash , Ayers, Emily C. , McKenna, Marshall, Tiger, Yun Kyoung , Sears-Smith, Megan , Peterson, Chelsea , Khan, Cyrus, Bliven, Sean Patrick , Narkhede, Mayur , Gibson, Alyssa, Munoz, Javier, Smith, Stephen D. , Hernandez‐Ilizaliturri, Francisco J. , Chinyengetere, Fadzai, Davé, Sandeep S. , Abdel-Razeq, Nayef , Hill, Brian T. , Brooks, Taylor R , Karimi, Yasmin H , Baron, Kelsey , Trotier, Daniel C , Pophali, Priyanka , Grover, Natalie S , Major, Ajay , Salafian, Kiarash , Ayers, Emily C , Brody, Joshua D , Sears-Smith, Megan , Peterson, Chelsea , Bliven, Sean P , Garza-Morales, Rodolfo , Ho, Carrie , Smith, Stephen D , Niu, Alex , Moustafa, Muhamad Alhaj , Wang, Yucai , Landsburg, Daniel J. , Hu, Boyu , Pophali, Priyanka A. , Grover, Natalie S. , Major, Ajay , Patel, Krish , Sundaram, Suchitra , Brody, Joshua , Ghosh, Nilanjan , Kline, Justin Paul , Munoz, Javier, Garza-Morales, Rodolfo , Niu, Alex , Moustafa, Muhamad Alhaj , Caimi, Paolo F.

Blood | July 15, 2025 | Volume: 146 | Issue: 18 | Pages: 2177-2188

10.1182/blood.2025029117 | PMID 40663785 Get It

Abstract Epcoritamab and glofitamab are CD20-directed bispecific antibodies (BsAbs) approved in the United States for relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL). Limited data exist for patients treated outside of trials. Patients with R/R DLBCL receiving commercial epcoritamab or glofitamab between 1 January 2023 and 15 October 2024 were collected from 21 United States institutions. Among 245 patients, 156 received epcoritamab and 89 received glofitamab, 113 were refractory to front-line therapy, 40 had MYC and BCL2 and/or BCL6 rearrangements, 147 received prior chimeric antigen receptor T-cell therapy, and 174 patients would have been ineligible for registrational trials. The overall response rate (ORR) for epcoritamab and glofitamab was 51% (23% complete response, [CR]) and 53% (30% CR), respectively. Median progression-free survival (PFS) was 2.6 months (95% confidence interval [CI], 2.0-3.8 months), and median overall survival (OS) was 7.8 months (95% CI, 6.2-11.0 months). The 6-month PFS was 36% (95% CI, 30-44) and the 6-month OS was 60% (95% CI, 54-67). Both trial ineligibility and undetectable CD20 pre-BsAbs portended shorter PFS and OS. Of 17 individuals with paired biopsies, 15 (88.2%) lost CD20 expression after BsAbs with a median time to progression of 3.7 months. This analysis including patients with R/R DLBCL shows the ORR to CD3/CD20 BsAbs was comparable to pivotal trials, although PFS and OS were lower. Baseline undetectable levels of CD20 were associated with poor outcomes. These results demonstrate the activity of BsAbs in R/R DLBCL, and underscore the importance of target antigen expression.
Habitual physical activity and sedentary behavior among women with and without premenopausal bilateral oophorectomy: an exploratory study
Jahanian, Omid , Kapoor, Ekta , Rocca, Walter A. , Kantarci, Kejal, Morrow, Melissa M. , Fortune, Emma , Kantarci, Kejal , LeBrasseur, Nathan, Morrow, Melissa M , Kantarci, Kejal , Jahanian, Omid , Winham, Stacey J. , LeBrasseur, Nathan K. , Mielke, Michelle M.

Menopause | July 15, 2025 | Volume: 32 | Issue: 9 | Pages: 829-837

10.1097/gme.0000000000002574 | PMID 40663581 Get It

Objective: To explore potential differences in physical activity and sedentary behavior volumes and patterns among postmenopausal women with and without premenopausal bilateral oophorectomy (PBO). Methods: Women with a history of PBO (n = 50) and age-matched postmenopausal referent women (n = 50) were recruited. Participants wore accelerometers on both ankles for 7 days. Volume metrics of sedentary behavior and physical activity, such as step counts, active time, and sedentary time, as well as the sedentary behavior and habitual physical activity distribution, and accumulation patterns, were quantified from the accelerometer data and compared between groups. Results: Metrics indicating volume of sedentary behavior and physical activity were not statistically different between groups. PBO was significantly associated with higher variability in stepping bout time ( P = 0.022), indicating a potentially more complex walking pattern. In addition, PBO was significantly associated with lower variability in sedentary break time ( P = 0.012), and lower activity time Gini index ( Z = −2.428, P = 0.015). This suggests that women with PBO may have broken up their sedentary time with shorter and less variable activity bouts, and because they had relatively shorter average daily active time, they might be at a higher risk of subsequent adverse health outcomes such as low bone mineral density. Conclusions: Although there were no differences in overall activity volume, some differences in activity patterns emerged between women with PBO and referent women. The study highlights the need for longitudinal research to understand how physical activity and sedentary behavior patterns evolve in postmenopausal women with a history of PBO.